Term
|
Definition
Allergic Response IgE Mediated Immediate response |
|
|
Term
|
Definition
Mediates the Type I allergic response Has special Fc that attaches to mast cells (1st exposure) Second exposure: allergen binds to two IgE receptors simultaneously which triggers mast cells to release histamine, prostaglandins, and other cytokines |
|
|
Term
|
Definition
What IgE binds to during allergic response during the first exposure Releases histamine, prostaglandins, and other cytokines when two allergens bind to two IgE receptors |
|
|
Term
Prostaglandin, histamine, leukotriene |
|
Definition
Released during the second exposure of an allergen Two allergens bind simultaneously to IgE receptors on mast cell and the mast cell releases those chemicals |
|
|
Term
|
Definition
Occurs during the first exposure to an allergen Mucus membrane class switch to IgA and IgE from IgM |
|
|
Term
|
Definition
Injected (not oral) allergen in small and gradually increasing doses causes serum B cells to produce IgG IgG competes with IgE for binding to allergen to prevent the release of histamines and cytokines Or you can use anti-IgE antibodies (to Fc part of IgE) to neutralize IgE so it can't bind to mast cells |
|
|
Term
|
Definition
Peanut allergy Causes smooth muscle dilation, dilators expand capillaries, diapedesis, hypovolemia, shock, and then death |
|
|
Term
|
Definition
Classic Type I HS Generalized reaction in the mucous membrane in nasal passages |
|
|
Term
|
Definition
Cytotoxicity HS Involves killing cells that express foreign antigens Antibody mediated via complement or NK cells Small molecule (hapten) binds to cell surface, or cells with different (non-self) surface proteins are introduced into the blood (blood transfusion) |
|
|
Term
|
Definition
The small molecule that binds to the cell surface Elicits a type II HS response (cytotoxicity) Isn't strong enough to elicit an immune response |
|
|
Term
|
Definition
Antibodies direct kiling of cells which they are bound to Antibody-Dependent Cell-Mediated Cytotoxicity |
|
|
Term
Hemolytic disease of the Newborn |
|
Definition
When the Mom is Rh- and the baby is Rh+ Baby's blood comes in contact with mom's at birth or with leaky placenta Rh factor is foreign to mom and she'll make IgM --> IgG A second Rh+ baby will elicit a secondary immune response which can kill the baby's blood cells |
|
|
Term
|
Definition
Anti Rh injected into the mom for HDN during and after Rh+ birth The anti Rh binds baby's blood and prevents mom from becoming Rh- sensitized |
|
|
Term
|
Definition
Immune complex disease Mediated by Ab/Ag agglutination into complexes Complexes get stuck in the basement membrane of the blood vessels Causes neutrophils to release digestive enzymes at blood vessel epithelial cells |
|
|
Term
|
Definition
Ab/Ag agglutination that turns into complexes A part of Type III HS |
|
|
Term
|
Definition
In a precipitation test, the presence of uncombined antigen above that required to combine with all of the antibody; precipitation may be inhibited because the presence of excess antigen gives rise to soluble antigen-antibody complexes type III |
|
|
Term
|
Definition
Where the complexes stick to in blood vessels Type III |
|
|
Term
|
Definition
Caused by activated complement Neutrophils release the enzymes responsible for much of the tissue damage in capillaries Type III |
|
|
Term
|
Definition
Delayed HS Mediated by TH cells and macrophages Response peaks in days, not minutes |
|
|
Term
|
Definition
|
|